Zobrazeno 1 - 10
of 221
pro vyhledávání: '"35"'
Publikováno v:
Thorax. 69:A159-A160
Introduction NICE guidelines recommend patients >35 yrs at risk of tuberculosis (TB) on screening, but without active disease, should not be offered latent TB infection (LTBI) treatment unless a healthcare worker, or HIV positive. This is based on pe
Autor:
G M Cochrane, J H Clark
Publikováno v:
Thorax. 30:300-305
We have examined the death certificates from all patients aged 35-64 years who were recorded as dying from asthma in Greater London Council hospitals in 1971. Of the 47 death certificates studied, nine suggested that the primary cause of death was no
Autor:
Jorge Lascano, George Z. Retsch-Bogart, James F Chmiel, Lisa Saiman, Joanne Billings, Sarah J. Morgan, Ada Kong, Arthur Baines, Jerry A. Nick, Nicole Mayer-Hamblett, Shannon Kirby, David P. Nichols, Pradeep K. Singh, Lindsay J. Caverly, Ronald L. Gibson, Sonya L. Heltshe, Hossein Sadeghi
Publikováno v:
Thorax. 77:581-588
RationaleInhaled tobramycin and oral azithromycin are common chronic therapies in people with cystic fibrosis and Pseudomonas aeruginosa airway infection. Some studies have shown that azithromycin can reduce the ability of tobramycin to kill P. aerug
Autor:
JS Schreiber, Claudia Mailaender
Publikováno v:
Thorax. 71:A151.2-A151
Introduction Proper evaluation of the allergic sensitizations is inevitable in treating severe asthma. Besides seasonal allergens, perennial aeroallergens have to be considered. However, within the German reimbursement system testing of only 8 allerg
Publikováno v:
Thorax. 71:A247.1-A247
Introduction Studies to test the delivered dose uniformity (DDU) and fine particle dose (FPD) delivery over inhaler life were performed with aclidinium bromide 400 μg/formoterol fumarate dihydrate 12 μg inhalation powder in the Genuair™* inhaler.
Publikováno v:
Thorax. 71:A145.1-A145
Introduction NICE 2016 Tuberculosis guidance recommends significant changes in contact screening. Tuberculin Skin Test (TST) is advocated for diagnosis of latent tuberculosis infection (LTBI), with a positive TST redefined as 5mm regardless of BCG st
Publikováno v:
Thorax. 53:638-642
BACKGROUND Figures for the prevalence of sleep apnoea syndrome range from 0.3% to 8.5%. These widely ranged estimates are probably due to differences in the definitions used, study designs, and study populations. A study was undertaken to determine t
Autor:
Yoshikazu Inoue, Yasuhiko Yamano, Noriyoshi Ogawa, Shiro Imokawa, Yasuhiro Kondoh, Motoyasu Kato, Yoshio Taguchi, Masafumi Masuda, Noriyuki Enomoto, Hirofumi Chiba, Takafumi Suda, Kazutaka Mori, Hajime Takizawa, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Naoki Koshimizu, Yutaro Nakamura, Yusuke Kaida, Sakae Homma, Miho Kanai, Takehisa Sano, Hiroshi Mukae, Shinyu Izumi, Hiroyuki Matsuda, Naoki Hamada, Hironao Hozumi, Taisuke Akamatsu, Tomoyuki Fujisawa, Shigeo Muro, Takeshi Saraya, Koshi Yokomura, Naohiko Inase, Hiroshi Ishii, Shinobu Akagawa, Hironori Uruga
Publikováno v:
Thorax. 77:143-153
BackgroundSome patients with idiopathic interstitial pneumonia (IIP) show autoimmune features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a research concept in these patients. However, retrospective studies report
Publikováno v:
Thorax. 53:363-367
BACKGROUND In acute asthma the optimal duration of treatment with combination β agonist and anticholinergic nebuliser solutions is unknown; most studies have investigated single doses or treatment for up to 12 hours. To determine whether longer trea
Publikováno v:
Thorax. 69:A143-A144
Introduction Difficult and slow weaning of ventilated patient will have been observed by staff in many critical care units 1 . A National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Conference suggested that 20% of such p